Register Login

Bio-Techne Corp (TECH)

Director Nusse Roeland 🟡 adjusted position in 80.6K shares (10 derivative) of BIO-TECHNE Corp (TECH) at $128.81 ($4.7M) Transaction Date: Aug 25, 2025 | Filing ID: 014993

Full text
Register to leave comments
  • News bot Aug. 27, 2025, 8:11 p.m.

    🔍 Nusse Roeland (Director)

    Company: BIO-TECHNE Corp (TECH)

    Report Date: 2025-08-25

    Transaction Summary:

    • Total transactions: 12
    • Derivative instruments: 10
    • Holdings reported: 9
    • Total shares acquired: 17,040
    • Total shares sold: 34,080
    • Total shares held: 63,544

    Detailed Transactions and Holdings:

    • Acquired 17,040 shares of Common Stock at $21.84 per share (Direct)
      Date: 2025-08-25 | Code: M | equity_swap_involved: 0 | shares_owned_after: 61,599.00 | transaction_form_type: 4
    • Sold 17,040 shares of Common Stock at $56.3608 per share (Direct)
      Date: 2025-08-25 | Code: S | equity_swap_involved: 0 | shares_owned_after: 44,559.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 17,040 shares of Stock Options (Right to Buy) at $21.84 per share (Derivative)
      Date: 2025-08-25 | Code: M | Expires: 2025-10-28 | Exercise: 2016-10-29 | equity_swap_involved: 0 | transaction_form_type: 4
    • Holds 15,940 shares of Stock Options (Right to Buy) at $25.3 per share (Derivative)
      Date: 2025-08-25 | Code: H | Expires: 2026-10-27 | Exercise: 2017-10-26 | shares_owned_after: 15,940.00
    • Holds 12,500 shares of Stock Options (Right to Buy) at $31.26 per share (Derivative)
      Date: 2025-08-25 | Code: H | Expires: 2027-10-26 | Exercise: 2018-10-25 | shares_owned_after: 12,500.00
    • Holds 7,592 shares of Stock Options (Right to Buy) at $44.96 per share (Derivative)
      Date: 2025-08-25 | Code: H | Expires: 2028-10-25 | Exercise: 2019-10-24 | shares_owned_after: 7,592.00
    • Holds 8,044 shares of Stock Options (Right to Buy) at $50.41 per share (Derivative)
      Date: 2025-08-25 | Code: H | Expires: 2029-10-24 | Exercise: 2020-10-24 | shares_owned_after: 8,044.00
    • Holds 6,028 shares of Stock Options (Right to Buy) at $63.92 per share (Derivative)
      Date: 2025-08-25 | Code: H | Expires: 2030-10-29 | Exercise: 2021-10-28 | shares_owned_after: 6,028.00
    • Holds 2,532 shares of Stock Options (Right to Buy) at $128.81 per share (Derivative)
      Date: 2025-08-25 | Code: H | Expires: 2031-10-28 | Exercise: 2022-10-27 | shares_owned_after: 2,532.00
    • Holds 3,460 shares of Stock Options (Right to Buy) at $73.94 per share (Derivative)
      Date: 2025-08-25 | Code: H | Expires: 2032-10-27 | Exercise: 2023-10-26 | shares_owned_after: 3,460.00
    • Holds 3,937 shares of Stock Options (Right to Buy) at $61.51 per share (Derivative)
      Date: 2025-08-25 | Code: H | Expires: 2033-10-26 | Exercise: 2024-10-24 | shares_owned_after: 3,937.00
    • Holds 3,511 shares of Stock Options (Right to Buy) at $68.37 per share (Derivative)
      Date: 2025-08-25 | Code: H | Expires: 2034-10-24 | shares_owned_after: 3,511.00 | Footnotes: F2

    Footnotes:

    • F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.21 to $56.33 inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
    • F2: The option vests on the earlier of the one year anniversary of the grant date (10/24/2024) or the date of Bio-Techne's 2025 annual meeting of shareholders.

Search

News categories